Order Article Reprints

Enright JM, Zhang S, Thebeau C, Siebert E, Jin A, Gadiraju V, Zhang X, Chen S, Semenkovich CF, Rajagopal R. Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression. Journal of Clinical Medicine. 2021; 10(1):126. https://doi.org/10.3390/jcm10010126

Enright, Jennifer M., Sheng Zhang, Christina Thebeau, Emily Siebert, Alexander Jin, Veda Gadiraju, Xiaodong Zhang, Shiming Chen, Clay F. Semenkovich, and Rithwick Rajagopal. 2021. "Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression" Journal of Clinical Medicine 10, no. 1: 126. https://doi.org/10.3390/jcm10010126

Enright, J. M., Zhang, S., Thebeau, C., Siebert, E., Jin, A., Gadiraju, V., Zhang, X., Chen, S., Semenkovich, C. F., & Rajagopal, R. (2021). Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression. Journal of Clinical Medicine, 10(1), 126. https://doi.org/10.3390/jcm10010126